Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Perinatol ; 40(3): 235-242, 2023 02.
Article in English | MEDLINE | ID: mdl-35777733

ABSTRACT

OBJECTIVE: The aim of the study is to determine whether stage 1 hypertension is a risk factor for cesarean at ≥390/7 weeks. STUDY DESIGN: This is a retrospective cohort study of nulliparas delivering at ≥390/7weeks. Exposure was defined as stage 1 hypertension and compared with normotension. The primary outcome was unplanned cesarean. Statistical analysis was performed using SPSS 27. RESULTS: Two hundred and fifty patients had stage 1 hypertension and 250 had normotension. Thirty-eight percent of the patients with stage 1 hypertension required cesarean as did 22% of controls (risk ratio [RR]=1.55, 95% confidence interval [CI]: 1.23-1.96, p <0.001). This remained significant after controlling for confounders in a logistic regression (odds ratio [OR]=1.61, 95% confidence interval [CI]: 1.02-2.55, p <0.040). Upon secondary analysis, these results were statistically significant for gestational age ≥395/7 weeks (adjusted odds ratio [AOR]=1.89, 95% CI: 1.05-3.39, p=0.033) but not from 390/7 to 394/7weeks (AOR=0.68, 95% CI: 0.31-1.50, p=0.34). CONCLUSION: In nulliparas, stage 1 hypertension is an independent risk factor for unplanned cesarean. KEY POINTS: · Stage 1 hypertension correlates with more cesareans.. · Unplanned cesarean for nonreassuring fetal status correlates with impaired placental function.. · Stages 1 and 2 hypertension carry similar risks..


Subject(s)
Hypertension , Placenta , Humans , Pregnancy , Female , Infant , Retrospective Studies , Cesarean Section/adverse effects , Parity
SELECTION OF CITATIONS
SEARCH DETAIL
...